Tirzepatide ke moriana o mocha o emelang katleho e kholo kalafong ea lefu la tsoekere la mofuta oa 2 le botenya. Ke agonist ea pele e 'meli ea li-receptor tse itšetlehileng ka tsoekere ea insulinotropic polypeptide (GIP) le glucagon-like peptide-1 (GLP-1). Mokhoa ona o ikhethang oa ts'ebetso o o khetholla ho liphekolo tse seng li ntse li le teng mme o etsa hore ho be le litlamorao tse matla taolong ea tsoekere ea mali le ho theola boima ba 'mele.
Ka ho kenya tšebetsong li-receptor tsa GIP le GLP-1, Tirzepatide e ntlafatsa secretion ea insulin le kutlo, e fokotsa secretion ea glucagon, e liehisa ho tsoa ka mpeng, 'me e fokotsa takatso ea lijo.
E tsamaisoa e le ente ea subcutaneous hanngoe ka beke, Tirzepatide e bonts'itse katleho e makatsang litekong tsa bongaka. E ntlafatsa haholo taolo ea glycemic mme e fokotsa boima ba 'mele, hangata e feta ts'ebetso ea meriana e teng hona joale. Ho phaella moo, melemo e ka 'nang ea e-ba teng ea lefu la pelo e hlokometsoe.
Litla-morao tse atileng haholo ke mala a mala, ho kenyelletsa ho nyekeloa ke pelo, letšollo le ho hlatsa, tseo hangata li leng bobebe ho isa ho tse itekanetseng ka matla 'me li atisa ho fokotseha ha nako e ntse e ea.
Ka kakaretso, nts'etsopele ea Tirzepatide e tšoaea moeli o mocha oa kalafo ea mafu a metabolic, e fanang ka sesebelisoa se matla sa ho laola lefu la tsoekere le botenya.
Nako ea poso: Sep-01-2025